Drug Trial Radar · NCT07740564
Phase III Study of OT202 in Treating Moderate to Severe Dry Eye
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
842
Planned (sponsor's estimate)
Start
Aug 25, 2026
Primary completion
Jan 2029
Study completion May 2029
Sponsor
- Lead sponsor
- Ocumension Therapeutics (Suzhou) Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jul 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 30 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial, enrolling 842 subjects with moderate to severe dry eye, who will be randomized at a 1:1 ratio to receive either 1% OT202 ophthalmic solution or vehicle control. The trial consists of screening, run-in, 8-week double-blind treatment period, and three long-term safety follow-up cohorts (10 weeks, 28 weeks, and 54 weeks), including 342 subjects for the 10-week follow-up, 350 subjects for the 28-week follow-up, and 150 subjects for the 54-week follow-up. Unblinding will be performed after the completion of double-blind treatment for all subjects, who will then receive open-label 1% OT202 ophthalmic solution uniformly. The co-primary efficacy endpoints are the change from baseline in Total Corneal Fluorescein Staining Score (TCSS) and Visual Analog Scale-Eye Dryness Score (VAS-EDS) at Day 56. Pharmacokinetic assessments will be conducted in 60 of the subjects assigned to the 54-weeks long-term safety follow-up. An interim futility analysis will be performed once approximately 30% of subjects complete the treatment period. Analysis of covariance (ANCOVA) will be utilized for efficacy statistical analyses. The primary objective is to evaluate the efficacy and safety of OT202 ophthalmic solution in the treatment of moderate to severe dry eye.
Conditions
- Dry Eye
Interventions
OT202 conc 1%Drug
Apply 1-2 drops of OT202 1% solution into the conjunctival sac. three times daily
PlaceboDrug
Apply 1-2 drops of placebo solution into the conjunctival sac. three times daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Corneal Fluorescein Staining (TCSS) scoreTime frame: Day 56
- Total visual analogue scale (VAS)-eye dryness score (EDS) scoreTime frame: Day 56
Locations
49 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China · Not yet recruiting
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China · Not yet recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Chongqing Aier Eye Hospital
Chongqing, Chongqing Municipality, China · Not yet recruiting
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China · Not yet recruiting
Xiamen Eye Center Affiliated to Xiamen University
Xiamen, Fujian, China · Not yet recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong
Shantou, Guangdong, China · Not yet recruiting
Shenzhen Eye Hospital
Shenzhen, Guangdong, China · Not yet recruiting
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China · Not yet recruiting
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Guiyang, Guizhou, China · Not yet recruiting
Hainan Eye Hospital of Zhongshan Ophthalmic Center, Sun Yat-sen University
Haikou, Hainan, China · Not yet recruiting
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Harbin No.242 Hospital
Harbin, Heilongjiang, China · Not yet recruiting
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China · Not yet recruiting
Zhengzhou Second Hospital
Zhengzhou, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Renmin Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China · Not yet recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Changsha Aier Eye Hospital
Changsha, Hunan, China · Not yet recruiting
Changzhou Third People's Hospital
Changzhou, Jiangsu, China · Not yet recruiting
Nanjing Medical University Eye Hospital
Nanjing, Jiangsu, China · Not yet recruiting
The First People's Hospital of Xuzhou
Xuzhou, Jiangsu, China · Not yet recruiting
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China · Not yet recruiting
Yanbian University Hospital
Yanji, Jilin, China · Not yet recruiting
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China · Not yet recruiting
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China · Not yet recruiting
The Fourth People's Hospital of Shenyang
Shenyang, Liaoning, China · Not yet recruiting
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, Ningxia, China · Not yet recruiting
Xi'an NO.1 Hospital
Xi'an, Shaanxi, China · Not yet recruiting
Xi'an People's Hospital (Xi'an Fourth Hospital
Xi'an, Shaanxi, China · Not yet recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China · Not yet recruiting
Qilu Hospital of Shandong University
Jinan, Shandong, China · Not yet recruiting
Qingdao Eye Hospital of Shandong First Medical University
Qingdao, Shandong, China · Not yet recruiting
Weifang Eye Hospital
Weifang, Shandong, China · Not yet recruiting
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China · Not yet recruiting
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.